Current guidance
65 items
Each item compared with the same item in the previous release (Apr 29, 2026). Values in quotation marks are the company’s words.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| New | Sales target | for FY2030 | — | “$14-$15 Billion” | Filing ↗ |
| Narrowed | Adjusted EBITDA | for FY2026 | “$750 to $850 million” | “$800 to $850 million” | Filing ↗ |
| New | Adjusted EBITDA outlook increase | for FY2026 | — | “approximately $25 million” | Filing ↗ |
| Lowered | Diluted Adjusted EPS | for FY2026 | “$2.00 to $3.00” | “$1.75 to $2.25” | Filing ↗ |
| Narrowed | Implied adjusted EBITDA margin | for FY2026 | “10.0% to 11.0%” | “~10.6%” | Filing ↗ |
| New | Eaton Mobility transaction close | for Q1 FY2027 | — | “first-quarter of 2027” | Filing ↗ |
| Raised | Adjusted free cash flow | for FY2026 | “$250 to $350 million” | “$275 to $375 million” | Filing ↗ |
| Raised | Net leverage | for FY2026 | “Less Than 1x” | “~1.4x” | Filing ↗ |
| Raised | Sales | for FY2026 | “$7.30 to $7.70 billion” | “$7.65 to $7.85 billion” | Filing ↗ |
| New | Sales outlook increase | for FY2026 | — | “approximately $225 million” | Filing ↗ |
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Not restated | Sales growth vs. mid 2026 Guide | for FY2030 | “~33%” | — | Filing ↗ |
| Not restated | Sales increase over 2026 outlook | for FY2030 | “a 33 percent increase” | — | Filing ↗ |
| Not restated | Adjusted EBITDA margin | for FY2026 | “midpoint of 10.7 percent” | — | Filing ↗ |
| Not restated | Diluted adjusted EPS basis (weighted average shares) | for FY2026 | “108.7 million weighted average shares” | — | Filing ↗ |
| Not restated | Margin midpoint | for FY2026 | “a midpoint of 10.7 percent” | — | Filing ↗ |
| Not restated | New Dana target adjusted EBITDA margins | for FY2026 | “9.5% - 10.5%” | — | Filing ↗ |
| Not restated | Adjusted EBITDA | No period stated | “~$990 million” | — | Filing ↗ |
| Not restated | Implied adjusted EBITDA margin | No period stated | “~10.0%” | — | Filing ↗ |
| Not restated | Capital return authorization | for FY2027 | “up to $1B” | — | Filing ↗ |
| Not restated | Capital return to shareholders authorized | for FY2027 | “$1B” | — | Filing ↗ |
| Not restated | BRL | for FY2026 | “5.50/USD” | — | Filing ↗ |
| Not restated | INR | for FY2026 | “87.00/USD” | — | Filing ↗ |
| Not restated | THB | for FY2026 | “32.28/USD” | — | Filing ↗ |
| Not restated | Total cost reduction target | for FY2026 | “$300 million” | — | Filing ↗ |
| Not restated | Cost-savings plan (total) | for the long term | “$300 million plan” | — | Filing ↗ |
| Not restated | Free cash flow | No period stated | “approximately four percent of sales” | — | Filing ↗ |
| Not restated | Free cash flow | for the long term | “approximately four percent of sales” | — | Filing ↗ |
| Not restated | Net leverage | No period stated | “1x” | — | Filing ↗ |
| Not restated | Net leverage target | for the long term | “~1x” | — | Filing ↗ |
| Not restated | Sales | No period stated | “~$9.9 billion” | — | Filing ↗ |
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Accretive new business (margin contribution) | “+60 bps” | for FY2026 | Company-defined | Aug 5, 2025 | 1 | Filing ↗ |
| Accretive new business contribution to margin | “+60 bps” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Additional operating performance contribution to margin | “+40 bps” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Additional operational performance (margin contribution) | “+40 bps” | for FY2026 | Company-defined | Aug 5, 2025 | 1 | Filing ↗ |
| Adjusted EBITDA | “$800 to $850 million” | for FY2026 | Company-defined | Feb 18, 2026 | 3 | Filing ↗ |
| Adjusted EBITDA margin | “~10.6%” | for FY2026 | Company-defined | Jan 24, 2025 | 2 | Filing ↗ |
| Adjusted EBITDA margin | “midpoint of 10.7 percent” | for FY2026 | Company-defined | Aug 5, 2025 | 2 | Filing ↗ |
| Adjusted EBITDA margins | “10 to 11 percent range” | for FY2026 | Company-defined | Aug 5, 2025 | 2 | Filing ↗ |
| Adjusted EBITDA margins (New Dana) | “10%-10.5%” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Adjusted EBITDA outlook increase | “approximately $25 million” | for FY2026 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Cost savings plan contribution to margin | “+100 bps” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Diluted Adjusted EPS | “$1.75 to $2.25” | for FY2026 | Company-defined | Feb 18, 2026 | 3 | Filing ↗ |
| Diluted adjusted EPS basis (weighted average shares) | “108.7 million weighted average shares” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Eliminated stranded costs (margin contribution) | “+50 bps” | for FY2026 | Company-defined | Aug 5, 2025 | 1 | Filing ↗ |
| Eliminated stranded costs contribution to margin | “+50 bps” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Implied adjusted EBITDA margin | “~10.6%” | for FY2026 | Company-defined | Feb 18, 2026 | 3 | Filing ↗ |
| Margin midpoint | “a midpoint of 10.7 percent” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| New Dana target adjusted EBITDA margins | “9.5% - 10.5%” | for FY2026 | Company-defined | Jan 24, 2025 | 1 | Filing ↗ |
| Additional cost savings to be realized | “~$65 million” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Additional share repurchases | “$200 million” | for FY2026 | Declared action | Aug 6, 2026 | 1 | Filing ↗ |
| Adjusted free cash flow | “$275 to $375 million” | for FY2026 | Company-defined | Feb 18, 2026 | 3 | Filing ↗ |
| Average cash balance | “~$400 million” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| BRL | “5.50/USD” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Cash taxes and interest | “~$200M” | for FY2026 | Company-defined | Aug 5, 2025 | 1 | Filing ↗ |
| Cash taxes and interest, lower by | “~$200M” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Cost reduction program target | “$310 million” | for FY2026 | Company-defined | Oct 29, 2025 | 1 | Filing ↗ |
| Cost savings | “~$65 million” | for FY2026 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Cost savings plan | “$310M” | for FY2026 | Company-defined | Aug 5, 2025 | 2 | Filing ↗ |
| Cost savings program total | “~$325 million” | for FY2026 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Cost savings to be realized | “~$65 million” | for FY2026 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Cost-reduction initiative | “$325 million” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| EUR | “1.16 USD/EUR” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Incremental new business growth | “$200 million” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| INR | “87.00/USD” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| MXN | “18.50/USD” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Net leverage | “~1.4x” | for FY2026 | Company-defined | Feb 18, 2026 | 2 | Filing ↗ |
| Sales | “$7.65 to $7.85 billion” | for FY2026 | Company-defined | Feb 18, 2026 | 3 | Filing ↗ |
| Sales outlook increase | “approximately $225 million” | for FY2026 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Share repurchase target | “~$300 million” | for FY2026 | Declared action | Apr 29, 2026 | 1 | Filing ↗ |
| Share repurchases | “up to $300 million” | for FY2026 | Declared action | Feb 18, 2026 | 1 | Filing ↗ |
| Stranded cost offset from Off-Highway sale | “~$40 million” | for FY2026 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Stranded costs offset | “~$40 million” | for FY2026 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Stranded costs to be substantially offset | “~$40 million” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| THB | “32.28/USD” | for FY2026 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Three-year net new sales backlog | “approximately $950 million” | for FY2026 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Total cost reduction target | “$300 million” | for FY2026 | Company-defined | Jan 24, 2025 | 1 | Filing ↗ |
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Adj. EBITDA Margin | “14%-15%” | for FY2030 | Company-defined | Feb 18, 2026 | 2 | Filing ↗ |
| Adj. EBITDA Margin improvement vs. mid 2026 Guide | “~400 bps” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Adj. FCF Margin | “~6%” | for FY2030 | Company-defined | Feb 18, 2026 | 2 | Filing ↗ |
| Adj. FCF Margin improvement vs. mid 2026 Guide | “~200 bps” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Adjusted EBITDA margin improvement versus 2026 | “a 45 percent improvement” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Adjusted EBITDA margins | “14 to 15 percent” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Adjusted free cash flow margin increase | “a 50 percent increase” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Adjusted free cash flow margins | “roughly 6 percent” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Sales | “approximately $10 billion” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Sales growth vs. mid 2026 Guide | “~33%” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Sales increase over 2026 outlook | “a 33 percent increase” | for FY2030 | Company-defined | Feb 18, 2026 | 1 | Filing ↗ |
| Sales target | “$14-$15 Billion” | for FY2030 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Share repurchase program target | “~$2 billion” | for FY2030 | Declared action | Apr 29, 2026 | 1 | Filing ↗ |
| Share repurchases | “approximately $2 billion” | for FY2030 | Declared action | Feb 18, 2026 | 1 | Filing ↗ |
| Share repurchase authorization completion | “$2 billion” | for FY2029 | Declared action | Aug 6, 2026 | 1 | Filing ↗ |
| Stellantis RAM Dakota program annual sales | “~$250M” | for FY2028 | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Capital return authorization | “up to $1B” | for FY2027 | Company-defined | Aug 5, 2025 | 1 | Filing ↗ |
| Capital return to shareholders authorized | “$1B” | for FY2027 | Company-defined | Aug 5, 2025 | 2 | Filing ↗ |
| Eaton Mobility transaction close | “first-quarter of 2027” | for Q1 FY2027 | Company-defined | Aug 6, 2026 | 1 | Filing ↗ |
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Adj. EBITDA CAGR (Dana 2030) | “17% CAGR” | for the long term | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Cost-savings plan (total) | “$300 million plan” | for the long term | Company-defined | Apr 30, 2025 | 1 | Filing ↗ |
| FCF CAGR (Dana 2030) | “11% CAGR” | for the long term | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
| Free cash flow | “approximately four percent of sales” | for the long term | Company-defined | Jan 24, 2025 | 1 | Filing ↗ |
| Net leverage target | “~1x” | for the long term | Company-defined | Aug 5, 2025 | 1 | Filing ↗ |
| Sales CAGR (Dana 2030) | “6% CAGR” | for the long term | Company-defined | Apr 29, 2026 | 1 | Filing ↗ |
Adjusted EBITDA, for FY2025 — every statement across the year, each linked to its filing.
12 companies in Autos & components. What they guide on, and who reported this season.
| General Motors | Oct 20, 2026 | 6 changes |
| Ford Motor | Oct 2, 2026 | 0 changes |
| Dana | Aug 6, 2026 | 10 changes |
| BorgWarner | Aug 5, 2026 | 13 changes |
| Goodyear Tire & Rubber | Aug 5, 2026 | 6 changes |
| Aptiv | Aug 4, 2026 | 18 changes |
| Allison Transmission | Aug 3, 2026 | 11 changes |
| Lear | Jul 31, 2026 | 5 changes |
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2030 | FY2029 | FY2028 | FY2027 | FY2026 | FY2025 | FY2024 | Long-term | No period |
|---|---|---|---|---|---|---|---|---|---|
| Accretive new business (margin contribution) | — | — | — | — | 1 statement | — | — | — | — |
| Accretive new business contribution to margin | — | — | — | — | 1 statement | — | — | — | — |
| Additional operating performance contribution to margin | — | — | — | — | 1 statement | — | — | — | — |
| Additional operational performance (margin contribution) | — | — | — | — | 1 statement | — | — | — | — |
| Adj. EBITDA (New Dana) | — | — | — | — | — | 2 statements | — | — | — |
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Aug 6, 2026 | FY2026 Q2 | 0001193125-26-336664 | 13 | Open filing ↗ |
| Apr 29, 2026 | FY2026 Q1 | 0001193125-26-188909 | 21 | Open filing ↗ |
| Feb 18, 2026 | FY2025 Q4 | 0001193125-26-056030 | 36 | Open filing ↗ |
| Oct 29, 2025 | FY2025 Q3 | 0001193125-25-254607 | 25 | Open filing ↗ |
| Aug 5, 2025 | FY2025 Q2 | 0001193125-25-173087 | 34 | Open filing ↗ |
| Apr 30, 2025 | FY2025 Q1 | 0001193125-25-105645 | 11 | Open filing ↗ |
| Jan 24, 2025 | FY2024 Q4 | 0001193125-25-011804 | 21 | Open filing ↗ |
| Oct 30, 2024 | FY2024 Q3 | 0001193125-24-246989 | 9 | Open filing ↗ |
4 values were detected in these releases but could not be matched to an exact sentence in the filing body, so they are not shown as guidance. We surface the count rather than drop it silently.
| Span | Why | Filed |
|---|---|---|
| Sales = ~$10 billion | span gate: value not verbatim in filing | Apr 29, 2026 |
| Sales = ~$10 billion | span gate: value not verbatim in filing | Feb 18, 2026 |
| Share Repurchase Target 2026-2030 = ~$1.35 billion | span gate: value not verbatim in filing | Feb 18, 2026 |
| Share Repurchase Target Total Through 2030 = ~$2.0 billion | span gate: value not verbatim in filing | Feb 18, 2026 |